Chapin Davis’s Pfizer PFE Stock Holding History

Chapin Davis’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Sell	48,605 -3,075	-6%	-$80.4K	0.21%	83
2026 Q1	$1.45M	Buy	51,680 +7,804	+18%	+$208K	0.32%	64
2025 Q4	$1.09M	Sell	43,876 -20,667	-32%	-$521K	0.26%	83
2025 Q3	$1.64M	Buy	64,543 +447	+0.7%	+$11K	0.4%	57
2025 Q2	$1.55M	Sell	64,096 -893	-1%	-$20.8K	0.43%	55
2025 Q1	$1.65M	Buy	64,989 +5,008	+8%	+$131K	0.56%	42
2024 Q4	$1.74M	Hold	59,981	–	–	0.57%	38
2024 Q3	$1.74M	Buy	59,981 +1,627	+3%	+$47.5K	0.56%	39
2024 Q2	$1.63M	Buy	58,354 +96	+0.2%	+$2.64K	0.56%	40
2024 Q1	$1.62M	Buy	58,258 +459	+0.8%	+$12.7K	0.59%	36
2023 Q4	$1.66M	Buy	57,799 +3,413	+6%	+$103K	0.7%	34
2023 Q3	$1.8M	Buy	54,386 +3,963	+8%	+$140K	0.86%	25
2023 Q2	$1.85M	Buy	50,423 +9,091	+22%	+$354K	0.88%	24
2023 Q1	$1.69M	Buy	41,332 +7,101	+21%	+$307K	0.87%	27
2022 Q4	$1.75M	Buy	+34,231	New	+$1.64M	1.02%	28

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Chapin Davis's PFE Position: Q2 2026 in Review

Chapin Davis reduced its Pfizer (PFE) stake by 6% in Q2 2026, selling an estimated $80.4K and leaving 48,605 shares worth $1.17M. The position accounts for 0.21% of the portfolio, ranked #83.

Chapin Davis first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.85M in Q2 2023. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Chapin Davis held 48,605 shares of Pfizer worth $1.17M as of Q2 2026.
Chapin Davis sold 3,075 Pfizer shares in Q2 2026, an estimated $80.4K.
Pfizer made up 0.21% of Chapin Davis's portfolio in Q2 2026, its #83 holding.
Chapin Davis first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
Chapin Davis's Pfizer position peaked at $1.85M in Q2 2023.
2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.